AMD
Advanced Micro Devices, Inc.
AMD has the edge over BMI overall, supported by stronger fundamentals and stronger modeled upside.
BMI
Badger Meter, Inc.
BMI has slightly lower modeled downside risk, despite its lower overall score.
AMD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AMD's revenue, profitability, cash flow and balance sheet are all currently strong.
BMI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
BMI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 39x | $585 | — |
| Cheap | 40x | $182 | -69% |
| Fair | 112x | $514 | -12% |
| Current | 127x | $585 | — |
| Expensive | 206x | $947 | +62% |
Historical ranges are pointers, not guarantees.
AMD's PE is in its fair range at 127x. If earnings grow as analysts expect, today's price would be 39x next year's earnings, in its cheap range.
BMI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 32x | $154 | — |
| Current | 35x | $154 | — |
| Cheap | 37x | $160 | +4.3% |
| Fair | 49x | $212 | +38% |
| Expensive | 55x | $238 | +55% |
Historical ranges are pointers, not guarantees.
BMI has the edge over AMD in the historical PE scenario, which offers more potential upside but is not a forecast.
AMD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Low |
AMD has the edge over BMI on the outlook, with more favorable revenue and profitability expectations.
BMI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect BMI's earnings to grow, with its revenue and profitability holding steady.
AMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $15.05 | +227% |
| Q3 2026 | $4.60 | +127% |
| Q2 2026 | $3.89 | +122% |
| Q1 2026 | $3.05 | +123% |
| Q4 2025 | $2.65 | +165% |
| Q3 2025 | $2.03 | +81% |
| Q2 2025 | $1.75 | +111% |
| Q1 2025 | $1.37 | +99% |
| Q4 2024 | $1.00 | +89% |
AMD has the edge over BMI on earnings, with more consistent year-over-year improvement.
BMI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.87 | +12% |
| Q3 2026 | $4.33 | -7.9% |
| Q2 2026 | $4.28 | -6.8% |
| Q1 2026 | $4.43 | -2.4% |
| Q4 2025 | $4.80 | +13% |
| Q3 2025 | $4.70 | +17% |
| Q2 2025 | $4.59 | +20% |
| Q1 2025 | $4.54 | +31% |
| Q4 2024 | $4.23 | +35% |
BMI earned $4.33 per share over the past year, down 7.9% from the year before.
AMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.4B | +45% |
| Q2 2026 | $11.5B | +50% |
| Q1 2026 | $10.3B | +38% |
| Q4 2025 | $10.3B | +34% |
| Q3 2025 | $9.2B | +36% |
| Q2 2025 | $7.7B | +32% |
| Q1 2025 | $7.4B | +36% |
| Q4 2024 | $7.7B | +24% |
AMD has the edge over BMI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +7.4 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 14% | +3.6 points |
| Q4 2025 | 17% | +5.7 points |
| Q3 2025 | 14% | +3.1 points |
| Q2 2025 | -1.7% | -6.4 points |
| Q1 2025 | 11% | +10 points |
| Q4 2024 | 11% | +5.8 points |
AMD has the edge over BMI on profitability, with a higher operating margin.
BMI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $235.9M | +0.1% |
| Q2 2026 | $222.3M | -6.6% |
| Q1 2026 | $202.3M | -9% |
| Q4 2025 | $220.7M | +7.6% |
| Q3 2025 | $235.7M | +13% |
| Q2 2025 | $238.1M | +9.9% |
| Q1 2025 | $222.2M | +13% |
| Q4 2024 | $205.2M | +12% |
BMI's revenue grew through 2024 and has held roughly level since: $236M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +0.7 points |
| Q2 2026 | 18% | -1.1 points |
| Q1 2026 | 17% | -4.8 points |
| Q4 2025 | 20% | +0.4 points |
| Q3 2025 | 20% | +0.1 points |
| Q2 2025 | 19% | -0.3 points |
| Q1 2025 | 22% | +3.6 points |
| Q4 2024 | 19% | +1.5 points |
BMI's operating margin was 20% last quarter, up 0.7 points from the same quarter a year ago, near the top of its range since 2019.
AMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $554M | -71% |
| Q2 2026 | $1.6B | -9.9% |
| Q1 2026 | $2.6B | +253% |
| Q4 2025 | $2.4B | +118% |
| Q3 2025 | $1.9B | +283% |
| Q2 2025 | $1.7B | +294% |
| Q1 2025 | $727M | +92% |
| Q4 2024 | $1.1B | +351% |
AMD has the edge over BMI on cash flow, with more consistent year-over-year improvement.
BMI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $40.3M | -16% |
| Q2 2026 | $21.9M | -46% |
| Q1 2026 | $29.5M | -2% |
| Q4 2025 | $50.8M | +7.1% |
| Q3 2025 | $48.2M | +15% |
| Q2 2025 | $40.6M | +19% |
| Q1 2025 | $30.1M | +60% |
| Q4 2024 | $47.4M | +32% |
BMI's free cash flow has been positive every quarter for seven years: $142M over the past year, down 14% from the year before.
AMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +2M shares |
| 1 year | +1.2% | +20M shares |
| 3 years | +2% | +32M shares |
| 5 years | +35% | +431M shares |
| Available history | +40% | +473M shares |
AMD has 1.7B diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $221M |
| Q4 2025 | — |
| Q3 2025 | $89M |
| Q2 2025 | $478M |
| Q1 2025 | $749M |
| Q4 2024 | $256M |
AMD has spent almost nothing on buybacks in the past year.
BMI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -271K shares |
| 1 year | -2.4% | -712K shares |
| 3 years | -1.9% | -550K shares |
| 5 years | -1.3% | -395K shares |
BMI has the edge over AMD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $55.5M |
| Q2 2026 | $25.3M |
| Q1 2026 | $38.2M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q4 2020 | $182,000 |
AMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | -1.0x | Net Cash |
| Q1 2020 | -0.8x | Net Cash |
| Q4 2019 | -1.2x | Net Cash |
AMD has more cash than debt.
BMI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.2x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
BMI has more cash than debt.
AMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.3 | Neutral |
| Stochastic | 41.4 | Neutral |
AMD's weekly RSI is 59 (neutral) and its Stochastic is 41 (neutral).
BMI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 74.5 | Neutral |
BMI's weekly RSI is 58 (neutral) and its Stochastic is 75 (neutral).
AMD PE vs Technology Sector
| Metric | AMD | Sector median | Relative |
|---|---|---|---|
| PE | 127x | 28x | 357% above |
| PE % | 61 | 35 | 26 pts above |
AMD is trading at 127x earnings, a 357% premium to the Technology sector's median of 28x.
BMI PE vs Technology Sector
| Metric | BMI | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 28x | 27% above |
| PE % | 14 | 35 | 21 pts below |
BMI has the edge over AMD on valuation relative to its sector.
AMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $557.2 | 5.1% above |
| 20 week MA | $525.9 | 11% above |
| 50 week MA | $389.7 | 50% above |
| 100 week MA | $266.9 | 119% above |
| 200 week MA | $199.6 | 193% above |
AMD has the edge over BMI on trend strength, trading above more of its moving averages.
BMI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $140.8 | 9.1% above |
| 20 week MA | $137.7 | 12% above |
| 50 week MA | $144.3 | 6.4% above |
| 100 week MA | $174.9 | 12% below |
| 200 week MA | $169.6 | 9.5% below |
BMI has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 9.5% below its 200-week average.
AMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.2 | $91.8 | +99% |
| 2021 | $91.8 | $146.1 | +59% |
| 2022 | $146.1 | $64.5 | -56% |
| 2023 | $64.5 | $147.4 | +128% |
| 2024 | $147.4 | $125.2 | -15% |
| 2025 | $125.2 | $215.0 | +72% |
| 2026 YTD | $215.0 | $585.3 | +172% |
AMD has the edge over BMI on returns for 2026, with the stronger performance.
BMI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $66.1 | $93.7 | +42% |
| 2021 | $93.7 | $105.2 | +12% |
| 2022 | $105.2 | $109.6 | +4.2% |
| 2023 | $109.6 | $154.4 | +41% |
| 2024 | $154.4 | $215.5 | +40% |
| 2025 | $215.5 | $180.8 | -16% |
| 2026 YTD | $180.8 | $153.6 | -15% |
BMI has finished higher in five of the last six years. It's down 15% so far in 2026.